Arkolith/Insider Trading/ADPT/Form 4

Robins Harlan S

Chief Scientific OfficerAdaptive Biotechnologies Corp (ADPT) · full profile →Form 4 · filed Jun 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.8M
Net Open-Market Flow
-$1.8M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 16, 2026Sell(S)6K$18.01$111K1.4M
Jun 15, 2026Sell(S)100K$17.37$1.7M1.4M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001780851-26-000013) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML